Varicella Vaccine Routine Two-Dose Regimen Not Recommended By CDC Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Disease Control & Prevention Advisory Committee on Immunization Practices declined to recommend routine second-dose varicella vaccination June 30
You may also be interested in...
Merck Files ProQuad MMR/Varicella Combo Pediatric Vaccine
Company expects action on the BLA for a combination of its M-M-R II and Varivax vaccines by "early July" 2005. Three additional Merck vaccines are slated for submission over the next year, including agents for HPV and shingles.
NME Slowdown Shows Market Pressure On Me-Toos, Not FDA Caution – Lutter
DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter
Amgen Aranesp, Vectibix Setbacks Illustrate Risks Of Real World Trials
Amgen's failed Anemia of Cancer trial of Aranesp and Panitumumab Advanced Colorectal Cancer Evaluation (PACCE) trial of Vectibix may illustrate the potential pitfalls facing sponsors that conduct "real world" trials of their products